**HealthCare Global Enterprises Ltd. (HCG) Unveils Strong Q2FY24 Results and Operational Highlights! **
Financial Snapshot:
- Q2FY24 Revenue: ₹4,869 Mn., a substantial 16% YoY growth.
- Q2FY24 EBITDA: ₹864 Mn., a robust 14% YoY increase.
- Q2FY24 PAT: ₹136 Mn., showing significant growth.
- Revenue Breakup: Mature Centers - ₹3,477 Mn. (13% YoY), Emerging Centers - ₹1,216 Mn. (29% YoY).
- EBITDA Breakup: Mature Centers - ₹832 Mn. (7% YoY), Emerging Centers - ₹122 Mn. (23% YoY).
Half-Yearly Performance (H1FY24):
- H1FY24 Revenue: ₹9,476 Mn., a strong 14% YoY growth.
- H1FY24 EBITDA: ₹1,629 Mn., reflecting a 15% YoY increase.
- H1FY24 PAT: ₹212 Mn., a remarkable 58% YoY growth.
Operational Highlights for Q2FY24:
- ARPOB: ₹42,054, up from ₹36,914 in Q2 FY23.
- AOR: 63.6%, maintaining strong operational efficiency.
-
RoCE (Q2FY24 Annualized):
- Mature Centers: 21.2%, RoCE pre-corporate allocations at 25.5%.
- Emerging Centers: -3.9%, RoCE pre-corporate allocations at -0.8%.
- High Double-Digit Growth: Key markets like Kolkata and Mumbai grew by 42% and 41% YoY.
- International Operations: Witnesses robust growth at 175% YoY.
Infrastructure Enhancement (Q2FY24):
- New Additions: 3 LINAC machines, 3 Robotics surgery machines in Mumbai, Kolkata & Baroda.
Leadership Insights:
- Dr. B.S. Ajaikumar, Executive Chairman: Highlights strides in outcome-driven cancer care, groundbreaking studies, and the acquisition of SRJ CBCC Cancer Hospital in Indore.
- Mr. Raj Gore, CEO: Emphasizes the commitment to patient outreach, capacity enhancement, and integration of acquired hospitals to extend cancer care services.
Subscribe To Our Free Newsletter |